Capturing Antibiotic Resistance Genes in the Human Gut Microbiome After Probiotic and Antibiotic Exposures
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Antibiotic-resistant bacteria and their often-untreatable infections are increasing globally.
The determinants that confer reduced susceptibility to antibiotics are encoded in the genetic
information, or genes, of bacteria. Sequencing-based approaches to identify antibiotic
resistance genes (ARGs) in diverse environments, such as the gut microbiome, are limited
in throughput and inaccessible due to high costs. The microbiome and its associated ARGs
are shaped by many factors throughout early life, which have yet to be fully characterized.
In this thesis, I developed an approach to capture ARGs in the gut microbiome and study
the effect of various early-life exposures.
First, I describe a set of over 37,000 probes to target over 2,000 ARGs. This targeted
sequencing approach was designed and validated against samples of DNA isolated from
multi-drug resistant bacteria. This probeset proved superior to metagenomic shotgun
sequencing in capturing the rare portion of ARGs from a human gut microbiome sample. Second, I investigated the potential benefits of providing probiotics to infants born preterm
in reducing antibiotic resistance in their gut microbiomes. Preterm infants that received
probiotics had a reduced burden of ARGs associated with potentially pathogenic bacteria
at 5 months of age compared to non-probiotic-supplemented preterm infants.
Finally, I explored the potential consequences of macrolide antibiotic exposure on ARGs
in the gut microbiome of children with diarrhoea in Botswana, Africa. Compared to the
standard treatment for diarrhoea, a three-day dose of azithromycin did not result in an
increased selection for ARGs after 60 days.
This thesis tackles the challenge of comprehensively detecting antibiotic resistance in the
gut microbiome. A better understanding of the impact of early-life exposures, including
probiotic and antibiotic treatments, in the prevention or maintenance of ARGs in the gut
microbiome of children will help reduce unnecessary selective pressures and the
persistence of antibiotic resistance into later life.